Candriam SCA’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-580,136
| Closed | -$1.52M | – | 715 |
|
|
2025
Q1 | $1.52M | Sell |
580,136
-1,149,063
| -66% | -$3.01M | 0.01% | 533 |
|
|
2024
Q4 | $7.12M | Buy |
1,729,199
+636,494
| +58% | +$2.62M | 0.04% | 307 |
|
|
2024
Q3 | $7.74M | Buy |
1,092,705
+389,276
| +55% | +$2.76M | 0.04% | 300 |
|
|
2024
Q2 | $4.59M | Buy |
703,429
+195,000
| +38% | +$1.27M | 0.03% | 353 |
|
|
2024
Q1 | $4.22M | Sell |
508,429
-212,641
| -29% | -$1.76M | 0.03% | 368 |
|
|
2023
Q4 | $7.94M | Sell |
721,070
-250,000
| -26% | -$2.75M | 0.05% | 283 |
|
|
2023
Q3 | $8.17M | Hold |
971,070
| – | – | 0.06% | 253 |
|
|
2023
Q2 | $12.2M | Sell |
971,070
-267,802
| -22% | -$3.36M | 0.09% | 220 |
|
|
2023
Q1 | $18.8M | Hold |
1,238,872
| – | – | 0.13% | 173 |
|
|
2022
Q4 | $18.5M | Buy |
1,238,872
+79,451
| +7% | +$1.19M | 0.12% | 176 |
|
|
2022
Q3 | $25.9M | Buy |
1,159,421
+601,604
| +108% | +$13.5M | 0.18% | 123 |
|
|
2022
Q2 | $9.34M | Buy |
557,817
+146,401
| +36% | +$2.45M | 0.08% | 232 |
|
|
2022
Q1 | $12.3M | Sell |
411,416
-118,469
| -22% | -$3.55M | 0.08% | 225 |
|
|
2021
Q4 | $16.3M | Sell |
529,885
-33,053
| -6% | -$1.02M | 0.1% | 201 |
|
|
2021
Q3 | $17.7M | Hold |
562,938
| – | – | 0.12% | 193 |
|
|
2021
Q2 | $20.6M | Buy |
562,938
+562,927
| +5,117,518% | +$20.6M | 0.14% | 172 |
|
|
2021
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 817 |
|